Clinical Trials Browser

Schwannomatosis, Behavior, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

NCT02129647 2021-12-01

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

13 enrolled 7 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT02934256 2021-09-09

Icotinib

Phase 2 Completed

10 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT03672838 2021-03-18

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Phase NA Completed

33 enrolled

CNS

Neurofibromatosis 1, Neurofibromatosis 2

NCT01767792 2021-02-12

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Phase 2 Completed

22 enrolled 14 charts

CNS

Neurofibromatosis 2

NCT01125046 2021-01-22

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Phase 2 Completed

50 enrolled 13 charts

CNS

Brain Neoplasms, Ependymoma, Meningioma, Neurofibromatosis 1, Neuroma, Acoustic, Neurofibromatosis 2

NCT00863122 2021-01-12

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Phase EARLY_PHASE1 Completed

26 enrolled 9 charts

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01880749 2020-05-13

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Phase EARLY_PHASE1 Completed

5 enrolled

CNS

Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT02811718 2018-08-17

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Phase NA Completed

45 enrolled

CNS

Neurofibromatosis 2

NCT03617276 2018-08-06

Reliability of Functional Outcome Measures in Neurofibromatosis 2

Completed

30 enrolled

CNS

Neurofibromatosis 2

NCT03210285 2018-07-23

NF2

Completed

70 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01419639 2017-07-18

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Phase 2 Completed

10 enrolled 4 charts

CNS

Ependymoma, Meningioma, Neurofibromatosis 2

NCT01490476 2017-05-23

AFINF2

Phase 2 Completed

10 enrolled

CNS

Vestibulocochlear Nerve Diseases, Neuroma, Acoustic, Otorhinolaryngologic Diseases, Peripheral Nervous System Diseases, Neurofibromatosis 2

NCT02104323 2017-02-09

Endostatin

Phase 2 Completed

20 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT02298270 2016-06-23

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Phase NA Completed

65 enrolled

CNS

Schwannomatosis, Neurofibromatosis 1, Neurofibromatosis 2, Neurofibromatoses

NCT00973739 2016-03-22

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase 2 Completed

21 enrolled 8 charts

CNS

Neurilemmoma, Neuroma, Acoustic, Neurofibromatosis 2

NCT00589784 2016-01-25

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

Phase 2 Completed

50 enrolled 6 charts

CNS

Brain Neoplasms, Meningioma, Neurofibromatosis 1, Neurofibromatosis 2, Central Nervous System Neoplasms, Neurofibromatoses, Hemangioblastoma

Clinical Trials

Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing

Study of Axitinib in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Icotinib

A Single Center Pilot Study to Assess the Intra-observer Reliability of Measuring Muscle Strength Using a Hand Held Dynamometer in Children and Adults With Neurofibromatosis Type 1 (NF1) and Type 2 (NF2)

Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Concentration and Activity of Lapatinib in Vestibular Schwannomas

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas

Resiliency Training for Patients With NF2 Via Videoconferencing With Skype

Reliability of Functional Outcome Measures in Neurofibromatosis 2

NF2

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

AFINF2

Endostatin

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma